Literature DB >> 26566912

Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome: a slowly progressive disorder with stereotypical presentation.

Daniele Cazzato1, Eleonora Dalla Bella1, Patrizia Dacci1, Caterina Mariotti2, Giuseppe Lauria3.   

Abstract

Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is a newly described condition with onset in adulthood, characterized by progressive balance impairment and sensory disturbances in the lower limbs, which can severely affect patients' quality of life. Its pathogenesis remains obscure and the diagnosis challenging. We described four patients complaining of slowly progressive gait unbalance and sensory disturbances at the feet followed, after a period ranging 2-6 years, by cerebellar dysfunction. All patients showed gait and limb ataxia, positive Romberg sign, cerebellar dysarthria, gaze-evoked nystagmus, absent deep tendon reflexes, and impaired vibratory sensation. Nerve conduction studies revealed axonal sensory neuropathy, brain magnetic resonance imaging showed cerebellar atrophy, and otoneurological investigation demonstrated bilateral vestibular areflexia with impaired vestibulo-ocular reflexes. The diagnosis of CANVAS should be suspected on clinical ground based on homogeneous course of symptoms and signs, and addressed by video-oculography eye movement recording.

Entities:  

Keywords:  CANVAS; Cerebellar; Eye movements; Sensory neuropathy; Vestibular

Mesh:

Year:  2015        PMID: 26566912     DOI: 10.1007/s00415-015-7951-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

Review 1.  Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video-oculographic diagnosis.

Authors:  David J Szmulewicz; John A Waterston; Hamish G MacDougall; Stuart Mossman; Andrew M Chancellor; Catriona A McLean; Saumil Merchant; Peter Patrikios; G Michael Halmagyi; Elsdon Storey
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

2.  Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.

Authors:  David J Szmulewicz; Catriona A McLean; Michael L Rodriguez; Andrew M Chancellor; Stuart Mossman; Duncan Lamont; Leslie Roberts; Elsdon Storey; G Michael Halmagyi
Journal:  Neurology       Date:  2014-03-28       Impact factor: 9.910

Review 3.  Bedside neuro-otological examination and interpretation of commonly used investigations.

Authors:  R Davies
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

4.  The neck-eye reflex in patients with reduced vestibular and optokinetic function.

Authors:  A M Bronstein; S Mossman; L M Luxon
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

Review 5.  Sensory neuron diseases.

Authors:  Angelo Sghirlanzoni; Davide Pareyson; Giuseppe Lauria
Journal:  Lancet Neurol       Date:  2005-06       Impact factor: 44.182

6.  Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome.

Authors:  D J Szmulewicz; J A Waterston; G M Halmagyi; S Mossman; A M Chancellor; C A McLean; E Storey
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

7.  Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome: a histopathologic case report.

Authors:  David J Szmulewicz; Saumil N Merchant; Gabor Michael Halmagyi
Journal:  Otol Neurotol       Date:  2011-10       Impact factor: 2.311

8.  Neurophysiological evidence for generalized sensory neuronopathy in cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.

Authors:  David J Szmulewicz; Linda Seiderer; G Michael Halmagyi; Elsdon Storey; Leslie Roberts
Journal:  Muscle Nerve       Date:  2015-01-05       Impact factor: 3.217

9.  Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign.

Authors:  Americo A Migliaccio; G Michael Halmagyi; Leigh A McGarvie; Phillip D Cremer
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

10.  The pivotal sign of CANVAS.

Authors:  Jens Alexander Petersen; Werner W Wichmann; Konrad Peter Weber
Journal:  Neurology       Date:  2013-10-29       Impact factor: 9.910

View more
  5 in total

Review 1.  An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics.

Authors:  Sanjog R Chintalaphani; Sandy S Pineda; Ira W Deveson; Kishore R Kumar
Journal:  Acta Neuropathol Commun       Date:  2021-05-25       Impact factor: 7.801

2.  Clinical Recognition of Sensory Ataxia and Cerebellar Ataxia.

Authors:  Qing Zhang; Xihui Zhou; Yajun Li; Xiaodong Yang; Qammer H Abbasi
Journal:  Front Hum Neurosci       Date:  2021-04-01       Impact factor: 3.169

3.  Preservation of Ia afferent function in peripheral neuropathies.

Authors:  David Burke; G Michael Halmagyi
Journal:  Clin Neurophysiol Pract       Date:  2021-05-11

Review 4.  Update on Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS).

Authors:  Mathieu Dupré; Ruben Hermann; Caroline Froment Tilikete
Journal:  Cerebellum       Date:  2020-10-04       Impact factor: 3.847

5.  Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion.

Authors:  Andrea Cortese; Stefano Tozza; Wai Yan Yau; Salvatore Rossi; Sarah J Beecroft; Zane Jaunmuktane; Zoe Dyer; Gianina Ravenscroft; Phillipa J Lamont; Stuart Mossman; Andrew Chancellor; Thierry Maisonobe; Yann Pereon; Cecile Cauquil; Silvia Colnaghi; Giulia Mallucci; Riccardo Curro; Pedro J Tomaselli; Gilbert Thomas-Black; Roisin Sullivan; Stephanie Efthymiou; Alexander M Rossor; Matilde Laurá; Menelaos Pipis; Alejandro Horga; James Polke; Diego Kaski; Rita Horvath; Patrick F Chinnery; Wilson Marques; Cristina Tassorelli; Grazia Devigili; Lea Leonardis; Nick W Wood; Adolfo Bronstein; Paola Giunti; Stephan Züchner; Tanya Stojkovic; Nigel Laing; Richard H Roxburgh; Henry Houlden; Mary M Reilly
Journal:  Brain       Date:  2020-02-01       Impact factor: 15.255

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.